C vs DERM · P/E 16, rev $85.22B vs rev $56.1M
Citigroup Inc. (C) versus Journey Medical Corp (DERM) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported DERM revenue for 2024-12-31 was $56.1M. Net income was -$14.7M. Revenue was down 29.1% from 2023-12-31 to 2024-12-31. DERM currently screens at market cap $163.1M.
C currently screens at market cap $214.73B and trailing P/E 15.5. DERM currently screens at market cap $163.1M.
Not investment advice. Open the C and DERM stock pages for the full models.
Not investment advice.